SEC Form 4
USANA Health Sciences Inc (USNA) insider trading
In the 12 months to Oct 26, 2026, 9 USNA insiders reported open-market sales of $990.6K across 16 filings; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $990.6K
- 16 filings · 9 insiders
- Open-market purchases
- $0
- 0 filings
Who traded USNA, and when
- Sale
USNA daily close from Oct 27, 2025 to Oct 26, 2026, between $12.86 and $23.24, last $13.83. 16 sale and 0 purchase filings by 9 insiders, marked at their filing dates. Paul A. Jones, CHIEF PEOPLE OFFICER: sold $232.0K across 2 filings, first filed May 29, 2026, last Jun 8, 2026. Joshua Foukas, CHIEF LEGAL OFFICER: sold $170.4K across 2 filings, first filed Feb 23, 2026, last May 8, 2026. Brent Neidig, CHIEF COMMERCIAL OFFICER: sold $147.8K across 2 filings, first filed Jun 16, 2026, last Jun 18, 2026. Peter Benedict, CHIEF INFORMATION OFFICER: sold $144.3K across 2 filings, first filed Dec 11, 2025, last Mar 3, 2026. G. Doug Iiekking, CHIEF FINANCIAL OFFICER: sold $100.5K across 1 filing, first filed May 28, 2026, last May 28, 2026. John Turman Fleming, Director: sold $78.6K across 2 filings, first filed Nov 3, 2025, last Jun 1, 2026. 3 others: sold $117.2K across 5 filings, first filed Nov 4, 2025, last May 26, 2026.
Largest mark · tap a row for others
Brent Neidig · CHIEF COMMERCIAL OFFICER
Filing 1 of 2 within a week · $147,769 total
Sale $50,465
2,511 shares at $20.10 avg
Filed Jun 16, 2026 · traded Jun 12
Close on filing date $19.01
Paul A. Jones · CHIEF PEOPLE OFFICER
CHIEF PEOPLE OFFICER
$232.0K soldJoshua Foukas · CHIEF LEGAL OFFICER
CHIEF LEGAL OFFICER
$170.4K soldBrent Neidig · CHIEF COMMERCIAL OFFICER
CHIEF COMMERCIAL OFFICER
$147.8K soldPeter Benedict · CHIEF INFORMATION OFFICER
CHIEF INFORMATION OFFICER
$144.3K soldG. Doug Iiekking · CHIEF FINANCIAL OFFICER
CHIEF FINANCIAL OFFICER
$100.5K soldJohn Turman Fleming · Director
Director
$78.6K sold3 others
Combined, one mark per week
$117.2K soldOpen-market trades
16 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Paul A. Jones | CHIEF PEOPLE OFFICER | $232.0K | — | 2 | — | |
| Joshua Foukas | CHIEF LEGAL OFFICER | $170.4K | — | 2 | — | |
| Brent Neidig | CHIEF COMMERCIAL OFFICER | $147.8K | — | 2 | — | |
| Peter Benedict | CHIEF INFORMATION OFFICER | $144.3K | — | 2 | — | |
| G. Doug Iiekking | CHIEF FINANCIAL OFFICER | $100.5K | — | 1 | — | |
| John Turman Fleming | Director | $78.6K | — | 2 | — | |
| Gilbert A. Fuller | Director | $60.4K | — | 3 | — | |
| Frederic J. Winssinger | Director | $38.4K | — | 1 | — | |
| David Mulham Mulham | CHIEF SALES OFFICER | $18.3K | — | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Brent Neidig CHIEF COMMERCIAL OFFICER | Sale | 5,002 | $19.45 | $97.3K | 0 | |
traded | Brent Neidig CHIEF COMMERCIAL OFFICER | Sale | 2,511 | $20.10 | $50.5K | 5,002 | |
traded | Paul A. Jones CHIEF PEOPLE OFFICER | Sale | 5,561 | $18.50 | $102.9K | 0 | |
traded | John Turman Fleming Director | Sale | 2,450 | $17.93 | $43.9K | 4,230 | |
traded | Paul A. Jones CHIEF PEOPLE OFFICER | Sale | 6,813 | $18.95 | $129.1K | 5,561 | |
traded | G. Doug Iiekking CHIEF FINANCIAL OFFICER | Sale | 5,360 | $18.75 | $100.5K | 0 | |
traded | Gilbert A. Fuller Director | Sale | 1,057 | $18.66 | $19.7K | 0 | |
traded | Joshua Foukas CHIEF LEGAL OFFICER | Sale | 3,791 | $19.82 | $75.1K | 0 | |
traded | Gilbert A. Fuller Director | Sale | 1,058 | $17.00 | $18.0K | 0 | |
traded | Peter Benedict CHIEF INFORMATION OFFICER | Sale | 4,553 | $19.38 | $88.3K | 0 | |
traded | Joshua Foukas CHIEF LEGAL OFFICER | Sale | 4,461 | $21.35 | $95.2K | 0 | |
traded | David Mulham Mulham CHIEF SALES OFFICER | Sale | 873 | $21.00 | $18.3K | 8,387 | |
traded | Peter Benedict CHIEF INFORMATION OFFICER | Sale | 2,673 | $20.95 | $56.0K | 0 | |
traded | Frederic J. Winssinger Director | Sale | 2,000 | $19.21 | $38.4K | 5,986 | |
traded | Gilbert A. Fuller Director | Sale | 1,057 | $21.48 | $22.7K | 0 | |
traded | John Turman Fleming Director | Sale | 1,750 | $19.79 | $34.6K | 4,565 |
GET /stocks/filings/vX/form-4?tickers=USNA&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"USNA"
],
"issuer_cik": "0000896264",
"owner_cik": "0001775522",
"accession_number": "0001775522-26-000008",
"form_type": "4",
"filing_date": "2026-06-18",
"period_of_report": "2026-06-16",
"issuer_name": "USANA HEALTH SCIENCES INC",
"issuer_trading_symbol": "USNA",
"owner_name": "Neidig Brent",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "CHIEF COMMERCIAL OFFICER",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-06-16",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 5002,
"transaction_price_per_share": 19.453,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 0,
"transaction_value": 97303.906,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "Weighted average price $19.453. Price range in multiple transactions was $19.35 to $19.68 inclusively."
}
]
},
{
"tickers": [
"USNA"
],
"issuer_cik": "0000896264",
"owner_cik": "0001775522",
"accession_number": "0000896264-26-000044",
"form_type": "4",
"filing_date": "2026-06-16",
"period_of_report": "2026-06-12",
"issuer_name": "USANA HEALTH SCIENCES INC",
"issuer_trading_symbol": "USNA",
"owner_name": "Neidig Brent",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "CHIEF COMMERCIAL OFFICER",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-06-12",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 1602,
"transaction_price_per_share": 20.15,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 5911,
"transaction_value": 32280.3,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 112 records
- Option exercises66 records
- Tax withholding46 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has USANA Health Sciences Inc's CEO sold stock?
No. Kevin Guest (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is USNA’s insider data?
These are USNA Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track USNA insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for USNA every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.